ClinicalTrials.gg
Not yet recruitingNCT07834775EFFETUpdated Nov 19, 2026

EFFET - Study of Executive Functions Regarding the Usability and User Experience of Assistive Technologies Among the Elderly

An interventional study of high executive load task and low executive load task in Gerontology, Cognitive Ability General and Technology Use, sponsored by University Hospital, Angers. Not yet recruiting at 3 sites in France. Open to participants aged 65 Years and older. Per ClinicalTrials.gov, last updated 2026-11-19.

Sponsored by University Hospital, Angers · Not applicable, Interventional, and Other

How we know

Updated Nov 19, 2026Start date movedPrimary completion moved+1 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
70
Allocation
Randomized
Ages
65 Years and older
Sex
All
01

Study summary

Population aging increases the strain on healthcare systems and highlights the value of gerontechnologies in promoting the autonomy and home-based living of older adults. However, their adoption remains limited, particularly due to age-related cognitive changes.

Cognitive Load Theory attributes certain difficulties in using digital technologies to the excessive demands placed on working memory. Yet, it provides limited insight into the executive functions involved in interface interaction-specifically inhibition, cognitive flexibility, and working memory updating. The concept of "executive load" may therefore provide a framework for examining examine how excessive demands on these functions affect user efficiency.

The primary objective of this study is to evaluate the impact of mental flexibility on the usability of a digital interface among individuals aged 65 or older living in senior residences who have an MMSE score of ≥ 24/30. Executive functions, cognitive reserve, technology acceptance, and digital skills are assessed during an initial visit.

Between 24 hours and one month later, participants perform a medical appointment-booking task on a tablet twice, using two interfaces that differ in executive load (low versus high). The order of interface presentation is randomized to control for potential order and practice effects. Performance, user experience, and cognitive load are recorded after each task.

The study aims to recruit 70 participants to obtain at least 50 complete datasets. Although the study offers no direct therapeutic benefit, it is expected to help better tailor gerontechnologies to the cognitive capabilities of older adults and facilitate the design of more accessible and inclusive digital interfaces, particularly in the healthcare sector.

02

Conditions studied

  • Gerontology
  • Cognitive Ability General
  • Technology Use

Keywords

  • Gerontology,
  • cognitive load
  • technology
  • executive function
03

In context

Lead sponsor

University Hospital, Angers is the lead sponsor of 481 studies on the registry; 122 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
65 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Be aged 65 or older
  • Reside in a partner senior living facility
  • Understand French
  • Have signed an form for participation
  • Be affiliated with or a beneficiary of a social security scheme
  • Present an (Mini-Mental State Examination) score of ≥ 24/30

Exclusion criteria

Exclusion Criteria:

  • Be subject to a legal protection measure
  • Have a major, uncorrected visual or hearing impairment preventing the reading of questionnaires, the completion of neuropsychological tests, or the use of a touchscreen tablet
  • Have a motor impairment of the upper limbs making the use of a touchscreen tablet impossible
  • Have a neurological or psychiatric condition likely to impair executive functions or participation in the assessment, including acute or progressive neurological disorders, significant neurological history, and unstabilized psychiatric disorders
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

MMSE and MoCA

Short tests of memory and thinking, each scored out of 30. Lower scores suggest more difficulty; criteria give a range, either to include people with memory problems or to leave them out.

05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Sequential assignment
Masking
None (open label)
Enrollment
70 participants (estimated)

Study arms

  • Other
    High-executive-load task first

    Participants realise high-executive-load task and then low-executive-load task

    Other: high executive load task · Other: low executive load task

  • Other
    low-executive-load task first

    Participants realise low-executive-load task and then high-executive-load task

    Other: high executive load task · Other: low executive load task

Interventions

  • Otherhigh executive load task

    high executive load task

  • Otherlow executive load task

    low executive load task

06

What researchers measure

Primary outcomes

  1. Correlation between Trail Making Test Z-score and usability score (low executive load)

    Evaluate the impact of mental flexibility on the usability of a digital interface =\> correlation between the Trail Making Test Z-score and the usability score (completion time in seconds) for the digital task under low executive load conditions. The Trail Making Test consists of two sheets (A and B). On sheet A, the participant must connect numbers in ascending order (time and number of errors are recorded). On sheet B, the participant must alternate between connecting numbers and letters (time, number of errors, and number of perseverations are recorded). A Z-score is calculated using the recorded scores.

    Time frame: Visit 1 (48 hours to 15 days after informing the participants), Visit 2 (24 hours to 1 month after visit 1)

Secondary outcomes

  1. Correlation between Trail Making Test Z-score and UEQ score (low executive load)

    Evaluate the impact of mental flexibility on user experience =\> correlation between the Trail Making Test Z-score and the UEQ score under conditions of low executive load. UEQ (26 items) : a questionnaire evaluating user experience across six dimensions: attractiveness, perspicuity, efficiency, dependability, stimulation, and novelty. These dimensions can be grouped into two subscales: pragmatic (efficiency, clarity, dependability) and hedonic (stimulation and novelty). Each item is rated on a scale of 1 to 7, with results converted into composite scores. A score close to +3 indicates a very positive experience, while a score close to -3 indicates a negative experience. The score for each UEQ dimension will be recorded. The questionnaire is administered via interviewer-led assessment (taking approximately 15 minutes).

    Time frame: Visit 1 (48 hours to 15 days after informing the participants), Visit 2 (24 hours to 1 month after visit 1)

  2. Correlation between Victoria Stroop Z-score and usability score (low executive load)

    Evaluate the impact of inhibition on usability =\> correlation between the Victoria Stroop Z-score and the usability score (completion time in seconds) under low executive load conditions. The Victoria Stroop test consists of three cards (color, word, and interference). On the color card, participants must name the color of 24 colored circles (time, corrected errors, uncorrected errors, and total errors are recorded). On the word card, they must read 24 words printed in colored ink (time, corrected errors, uncorrected errors, and total errors are recorded). On the interference card, they must name the ink color of 24 words denoting a different color (e.g., the word "red" printed in yellow ink); time, corrected errors, uncorrected errors, and total errors are recorded. A Z-score is calculated based on the recorded scores.

    Time frame: Visit 1 (48 hours to 15 days after informing the participants), Visit 2 (24 hours to 1 month after visit 1)

  3. Correlation between Victoria Stroop Z-score and UEQ score (low executive load)

    Evaluate the impact of inhibition on the user experience =\> correlation between the Victoria Stroop Z-score and the UEQ score under low executive load conditions.

    Time frame: Visit 1 (48 hours to 15 days after informing the participants), Visit 2 (24 hours to 1 month after visit 1)

  4. Correlation between 2-back and usability scores (low executive load)

    Evaluate the impact of the update on usability =\> correlation between the 2-back d'score and the usability score (completion time in seconds) under low executive load conditions. The 2-back task involves presenting a series of 30 letters one by one. For each letter presented, the participant must indicate-by pressing a keyboard key-whether it is identical to the letter presented two items previously. It yields five metrics: the number of correctly detected targets, false alarms, missed targets, correctly rejected targets, and the d-prime (d') score. The d' score is used as the primary metric.

    Time frame: Visit 1 (48 hours to 15 days after informing the participants), Visit 2 (24 hours to 1 month after visit 1)

  5. Correlation between 2-back and the UEQ scores (low executive load)

    Evaluate the impact of the update on the user experience =\> correlation between the 2-back d'score and the UEQ score under low executive load conditions.

    Time frame: Visit 1 (48 hours to 15 days after informing the participants), Visit 2 (24 hours to 1 month after visit 1)

  6. MDPQ-16 score

    Describe the participants' level of digital skills (control variable) =\> score on the MDPQ-16 questionnaire. Technological skills will be measured using the Mobile Device Proficiency Questionnaire (MDPQ-16), which assesses proficiency in using mobile devices (smartphones and tablets) among older adults. The MDPQ-16 questionnaire consists of 16 items rated on a 5-point Likert scale ranging from 1 ("Never done") to 5 ("Very easily"), with a maximum total score of 80. It is administered via interviewer assessment (taking approximately 5 minutes), and the score for each Likert scale item is recorded.

    Time frame: Visit 1 (48 hours to 15 days after informing the participants)

  7. CRI-q score

    Describe the participants' level of cognitive reserve (control variable) =\> score on the CRI-q questionnaire. CRI-q questionnaire evaluates four dimensions: CRI Total, CRI Education, CRI Work, and CRI Leisure. Responses to each item will be recorded. Each dimension yields a standardized score, calculated using an Excel file provided by the authors. This questionnaire is normed for ages up to 102. It is administered via interviewer assessment (taking approximately 15 minutes).

    Time frame: Visit 1 (48 hours to 15 days after informing the participants)

  8. STAM score

    Describe the participants' level of technology acceptance (control variable) =\> score on the STAM questionnaire. Attitudes toward technology will be measured using the S-STAM (Short-Senior Technology Acceptance Model), a 14-item questionnaire covering four dimensions: attitudes (3 items), control (4 items), anxiety (2 items), and health (5 items). Each item is rated on a Likert scale from 1 to 10. The maximum score is 140. Scores for each Likert scale are recorded. Developed for older adults, it is administered via interviewer assessment (taking approximately 10 minutes).

    Time frame: Visit 1 (48 hours to 15 days after informing the participants)

  9. Usability score (low vs. high executive load)

    Compare the usability score between the low executive load interface and the high executive load interface =\> comparison of the usability score (completion time in seconds) between the two experimental conditions (low vs. high executive load).

    Time frame: Visit 2 (24 hours to 1 month after visit 1)

  10. User experience score (low vs. high executive load)

    Compare the user experience score between the low executive load interface and the high executive load interface =\> comparison of the UEQ score between the two experimental conditions (low vs. high executive load).

    Time frame: Visit 2 (24 hours to 1 month after visit 1)

  11. Perceived cognitive load score (low vs. high executive load)

    Compare the perceived cognitive load score between the low executive load interface and the high executive load interface =\> comparison of the perceived cognitive load score between the two experimental conditions (low vs. high executive load).

    Time frame: Visit 2 (24 hours to 1 month after visit 1)

07

Study locations

3 sites
08

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it moved

Start is estimated for Jan 2027; primary completion for Jul 2028, 18 months later.

Since we started tracking on Sep 25, 2026, the dates moved once, on Nov 19, 2026: start Oct 2026 → Jan 2027, primary completion Apr 2028 → Jul 2028 and completion May 2028 → Sep 2028.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Sep 8, 2026
First posted
Sep 22, 2026
StartEst.
Jan 15, 2027was Oct 2026
Primary completionEst.
Jul 15, 2028was Apr 2028
CompletionEst.
Sep 1, 2028was May 2028
Last update
Nov 19, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Start date
Oct 1, 2026→Jan 15, 2027
Nov 19, 2026
Primary completion
Apr 1, 2028→Jul 15, 2028
Nov 19, 2026
Study completion
May 15, 2028→Sep 1, 2028
Nov 19, 2026
Show all 1 update
  1. Nov 19, 2026
    Start date Oct 1, 2026→Jan 15, 2027
    Primary completion Apr 1, 2028→Jul 15, 2028
    Study completion May 15, 2028→Sep 1, 2028
    + 1 other change: verification date

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

09

Registry details

Key details

Study ID
NCT07834775
Responsible party
Sponsor
First posted
Sep 22, 2026
Start date
Jan 15, 2027 (estimated)
Primary completion
Jul 15, 2028 (estimated)
Completion
Sep 1, 2028 (estimated)
Last update
Nov 19, 2026

Study contacts

Emma COMBRET, Psychologist
Contact
emma.combret@etud.univ-angers.fr
+33 0241355030
Frédéric NOUBLANCHE
Contact
FrNoublanche@chu-angers.fr
+33 0241355030

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion